Novavax shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Novavax (NVAX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Novavax
Tip: Access up to 7 years of quarterly data
All positions including Novavax held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Novavax by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.0M | 48k | 21.28 |
| 2023-09-30 | $386k | 53k | 7.26 |
| 2023-06-30 | $394k | 53k | 7.43 |
| 2023-03-31 | $401k | 58k | 6.93 |
| 2022-12-31 | $474k | 46k | 10.27 |
| 2022-03-31 | $3.3M | 44k | 73.65 |
| 2021-12-31 | $31M | 217k | 143.07 |
| 2021-09-30 | $97M | 466k | 207.31 |
| 2021-06-30 | $83M | 390k | 212.31 |
| 2021-03-31 | $149M | 823k | 181.31 |
| 2020-12-31 | $39M | 346k | 111.51 |
| 2020-09-30 | $21M | 191k | 108.35 |
| 2020-06-30 | $19M | 229k | 83.35 |